Bruce Altevogt
Bruce Altevogt is Vice President and Head External Medical Engagement within Pfizer Inc.’s Hospital Business Unit. In this role Dr. Altevogt is responsible for establishing and managing the business unit’s scientific and medical stakeholder engagement strategy. In addition, the External Medical Team supports the industry leading AMR surveillance program, ATLAS. Prior to this role he was a Senior Director of Science Policy and Science Advocacy within Global Policy and International Public Affairs. In this role Dr. Altevogt was responsible for managing policy issues in support of Pfizer’s research & development enterprise, vaccines and was lead for anti-microbial resistance policy. Dr. Altevogt serves as the Board Chair of Healthcare Ready, a non-profit organization that helps to strengthen healthcare supply chains by addressing pressing issues before, during, and after disasters. In addition he serves a member of the AMR Alliance Board, an organization that measures and drives the life-sciences industry progress to curb antimicrobial resistance.
Prior to joining Pfizer Inc. Dr. Altevogt served as a senior program officer on the Board on Health Sciences Policy at the Institute of Medicine (IOM). While at the IOM he led policy initiatives related to basic and translational research, drug discovery and development, and preparedness for catastrophic events. He oversaw the publication of over 50 IOM reports and directed multiple IOM studies. In his capacity at the IOM he served as director of the Forum on Medical and Public Health Preparedness for Catastrophic Events, the Forum on Neuroscience and Nervous System Disorders Forum, and number or additional activities.
Dr. Altevogt received a doctorate from Harvard University’s Program in Neuroscience and a B.A. from the University of Virginia, where he majored in Biology and minored in South Asian Studies. He is a published author of multiple scientific articles.